eHEALTH - Health

EPORT
ehealth.eletsonline.com RENCE R
CONFE
VISIT OUR WEBSITE TO GET LATEST UPDATES ON HEALTHCARE AND SUMMITS
volume 12 / issue 06 / JUNE 2017 / ` 75 / US $10 / ISSN 0973-8959
cover story
Unfolding Future Growth Potential
special feature special STORY

YEARS OF
Making India Global Wellness Hub
MODI GOVERNMENT
Transforming India’s Healthcare Landscape
INTERVIEWS
SPECIAL
INSIDE
R PRASANNA SANJAY DAVID SWADEEP SRIVASTAVA CHANDER SHEKHAR SIBAL

Government of Chhattisgarh Siemens Healthineers India India Virtual Hospital Fujifilm India
marketing@randox.com
randoxqc.com
+91 80 2802 500
4
Published by
Elets Technomedia Pvt Ltd
EDITOR-IN-CHIEF HYDERABAD BUREAU WEB DEVELOPMENT LEAD
Dr Ravi Gupta Senior Correspondent: Sudheer Goutham Farhan Khan

ADMINISTRATION
EDITORIAL TEAM: DELHI/NCR LUCKNOW BUREAU
Director: Archana Jaiswal
Senior Assistant Editors: Souvik Goswami, Assistant Editor: Arpit Gupta
Gautam Debroy EDITORIAL & MARKETING
AHMEDABAD BUREAU CORRESPONDENCE
Assistant Editors: Sandeep Datta,
Vivek Ratnakar, Priyanka Sharma Assistant Editor: Hemangini S Rajput eHealth – Elets Technomedia Pvt Ltd: Stellar IT Park
Office No: 7A/7B, 5th Floor, Annexe Building, C-25,
Sector-62, Noida, Uttar Pradesh - 201301,
Senior Correspondents: Shivani Tyagi, ODISHA BUREAU Phone: +91-120-4812600, Fax: +91-120-4812660,
Akash Tomer Email: info@elets.in
Senior Correspondent: Biswajit Sahoo
Correspondents: Rashi Aditi Ghosh, Rajbala Printed at Vinayak Print Media, D - 249, Sector-63,
Noida 201 307. UP and published from 710, Vasto
SALES & MARKETING TEAM Mahagun Manor, F-30 Sector-50, Noida, UP
BENGALURU BUREAU
National Manager: Bhupesh Tewari Editor - in - Chief: Dr Ravi Gupta
Associate Editor:T Radha Krishna
Senior Executive: Nilender Kumar © All rights reserved, No part of this publication may be
reproduced or transmitted in any form or by any means,
MUMBAI BUREAU electronic and mechanical, including photocopy, or any
SUBSCRIPTION & CIRCULATION
information storage or retrieval system, without
Senior Assistant Editor: Kartik Sharma TEAM publisher’s permission.
Senior Correspondent: Poulami Manager, Subscription:

Chakraborty +91-8860635832, subscription@elets.in Our Publications and Initiatives
Correspondent: Harshal Yashwant Desai
DESIGN TEAM
JAIPUR BUREAU
Creative Heads: Pramod Gupta, CONFERENCE | AWARDS | EXPO
Senior Assistant Editor: Kartik Sharma Anjan Dey

Deputy Art Directors: Om Prakash Thakur,
CHANDIGARH BUREAU
Gopal Thakur, Shyam Kishore
Assistant Editor: Priya Yadav Senior Graphic Designer: Pradeep G
Like us on ehealthmagazine Follow us on ehealthonline Connect with us on ehealthmagazine
Send your feedback about our interviews, features, articles, and news. You can either comment on the webpage of the story, or mail at editorial@elets.in
18
June 2017 | Volume 12 | Issue 06
Special feature
Medical Tourism:
12
Making India Global Wellness Hub
COVER STORY 32
product lAunch
Cardiology & ECG Equipment:
Unfolding Future Growth Potential
Schiller DS20 Making Routine
14
Check-ups Modern, Simple & Faster
Policymaker’s perspective
New Technology Changing Rural
38
HEALTHCARE INNOVATIONS
Landscape
R Prasanna Philips Intelli Safari: Taking Affordable
Commissioner, Health Services Health Tech Closer to the Masses
Government of Chhattisgarh
industry perspective 40
Special story
16 India Virtual Hospital:
Empowering Medical Travellers
Swadeep Srivastava Three Years of Modi Government
Managing Partner Transforming India’s Healthcare Landscape
42
India Virtual Hospital
17 Hospital Companion:
A Service for Patient Convenience
Dr Tarun Sahni industry feature
Advisor, India Virtual Hospital and
Senior Consultant, Internal and Envisioning Cardiovascular Therapeutics
Hyperbaric Medicine, Indraprastha in Next Decade
Apollo Hospitals-New Delhi Tapan Ghose
22 mCURA: Offering Effective Solution Director and Head
to Indian Health System Department of Cardiology
Dr Paparao Nadakuduru Fortis Flt. Lt. Rajan Dhall Hospital
Senior Consultant Physician, KIMS
Hospital, Kondapur
26 Fujifilm: Offering Quality Diagnostic
Solutions for Healthy India
46
Conference Report
Chander Shekhar Sibal
Executive Vice President
Fujifilm India
28 Siemens Healthineers: Leveraging
Technology to Take on Heart Diseases
Sanjay David
Head of CT in India on Cardiovascular
CT/Coronary CT Angiography
Siemens Healthineers India
34 Making End-To-End Primary
Healthcare Service A Reality in India
Manasije Mishra
Managing Director
Indian Health Organisation &
Aetna India
7
Care with confidence
Increased accuracy, higher productivity, maximum uptime and compliance…

You probably think this will cost a lot. Not with Barco displays.
Our diagnostic displays have been designed to minimize image manipulations
so you can improve workflow. They unveil the smallest details so you can
on the market.
So you can be confident about every decision you make, in every way.
www.barco.com/healthcare
Barco -India
A-38, A B&C, Sector-64, Noida-201301,U.P. JUNE 2017 | ehealth.eletsonline.com
+91-120-4020000 | +91-9971441118 | sales.in@barco.com
8
Editorial
Realising Growth Potential of Cardiology and ECG Equipment
Critical medical care for patients suffering from non-communicable diseases, like
cardio-vascular diseases, is a growing concern for India. According to a reputed
medical journal Lancet, over 60 per cent of the world’s heart patients will soon be
found in India.
However, another way to look at this huge challenge is to find ways to increase
heartcare in the country. It is in this context that a huge opportunity lies ahead for
cardiology and ECG manufacturers in the country. Our cover story, Cardiology and
ECG Equipment -- The Unfolding Future Growth Potential, in the June issue of eHealth
magazine, attempts to find out potential areas of growth for the industry, even as it
revisits the challenges ahead.
In the last two decades, the medical tourism and wellness sector have evolved as
the leading sectors of the Indian economy with a considerable contribution to the
national income, trade, investment and employment. Our special feature, Medical
Tourism -- Making India Global Wellness Hub, discusses the multi-faceted contribution
by the sector in detail and why the country needs to utilise one of its biggest inherent
strengths to raise its share in global healthcare market.
High on innovation, a rising demand and rejuvenated confidence to translate
opportunities into success, the Indian pharmaceutical industry, which is among the
top three in terms of volume globally, is growing in leaps and bounds. However, much
of this growth will depend on Indian pharma companies’ capacity to adopt Information
Technology to drive their productivity and improve efficiency.
Keeping in view increased digital adoption by the pharma industry, we recently
organised Pharma CIO Symposium in Mumbai in April with an aim to bring synergy
to this growth process. Emerging as an ideal platform for CIOs and other industry
stakeholders across organisations, the symposium helped to bring more clarity on
opportunities and challenges. This latest issue of eHealth magazine carries a detailed
conference report to help our readers gain useful insights from the leaders of the
industry.
As part of our endeavour to create a knowledge-sharing platform for the Indian
healthcare industry to meet, discuss, deliberate and decide on the future roadmap for
the industry, we are organising the 7th Healthcare Leaders Forum in Delhi on June 30.
We look forward to seeing you there and be a part of the ongoing revolution in health
space that is geared to make delivery of health services more affordable, accessible
and inclusive.
Dr Ravi Gupta
Editior - in - Chief
Elets Technomedia Pvt. Ltd
ravi.gupta@elets.in
21
Front loading Syringe pump Advanced Syringe pump
- Stackable with drug library - stackable
YEARS OF AKAS
TRUSTED SINCE 1996
Thank You Customers
A MAX
12.1” PATIENT MONITOR ECG + SPO2 + NIBP Monitor
NELLCOR
Original Module Option
Available
DUO II QVS-100
NIBP + SPO2 Monitor
QUICK VITAL SIGN
Andhra Pradesh Kerala Tamil Nadu Infusion, Syringe Pumps

Bihar Madhya Pradesh Telangana Patient Monitors, Oxygen Concentrator,
1/2/3 Para Monitors
Chhattisgarh Maharashtra Uttarakhand
MP / AI / 01 / 2017
Gujarat Mumbai Uttar Pradesh Ophthalmology Division

LCD Vision Chart, A-Scan, B-Scan
Haryana Odisha West Bengal
Jharkhand Punjab Clinical Division
Karnataka Rajasthan Patient Spot Test, Infusion Controller
Mob: +91 98403 79116

240/1, Periya Colony, Athipet, Ambattur, Chennai 600 058. Tamilnadu, Indian. Ph:+91 44 3253 3333 Fax:+91 44 2635 0030 Email: sales@akasmedical.com
#HLF_Delhi | @ehealthonline
Creating a road Map for inclusive hlf.eletsonline.com
HealtHCare in india
• •
•
•
•

•
•
•
•
• •
•
• •
• •
•
• •
•
•
•
Why should you Attend ?

www.fujifilm.in
We Accelerate
the Innovations
in Healthcare
As a pioneer of healthcare, we believe it is our mission and duty to shape
the future of healthcare, with state-of-the-art technologies, outstanding
products, and reliable services. Powered by the robust research, we
serve the healthcare service providers, enterprises, and consumers, with
industry’s most complete, end-to-end portfolio of products.
FDR Solutions | FCR Solutions | Mammography Solutions | Dry Imagers | SYNAPSE (PACS) | DRI-CHEM
Fujifilm India Private Limited, Vatika Business Park, Block 1, 7th Floor, Tower-A, Gurgaon Sohna Road, Sector-49, Gurgaon-122018
Contact Number: +91-(0)124-4325500, Fax :+91-(0)124-4325555, Email: medical@fujifilm.com
12
COVER STORY
Cardiology & ECG

Equipment Growth Potential
Unfolding Future
Increasing incidences of non-communicable diseases like heart

failure in India points towards the potential for cardiology and
ECG equipment to rise in the country. Therapeutic devices like
coronary stents, peripheral stents, vascular stent grafts, and
artificial heart valves will be utilised in more numbers, writes
Vivek Ratnakar of Elets News Network (ENN).
JUNE 2017 | ehealth.eletsonline.com

13
P
ointing out heart failure as He also says that utilisation of invasive therapy. It offers its products
COVER STORY
an important global health implantable defibrillator implantation for the treatment of arterial diseases,
problem, the reputed medical (ICD), cardiac resynchronisation which include coronary artery and
journal Lancet in a recent study therapy (CRT-D and P) utilisation peripheral vascular diseases.
said that India will soon have nearly will grow many fold in coming years
60 per cent of the world’s heart in India. But not many Indian cardiology
patients. The study was aimed at equipment manufacturers are well
measuring mortality in one year Therapeutic devices like coronary knows as Vascular Concepts is in the
in patients with heart failure in stents, peripheral stents, vascular global market. Although separate
India along with Africa, China, the stent grafts, artificial heart valves both data are not available for cardiology
Middle East, Southeast Asia and (mechanical and bioprosthetic) valves equipment, it too suffers a huge
South America. The researchers also will be utilised in more numbers. import dependency. It presents a huge
explored demographic, clinical, and Advent of non-surgical technique challenge for the industry.
socioeconomic variables associated of TAVR (non surgical aortic valve
with mortality. replacement) is a boon for the heart The Indian medical device market
patients. There is an urgent need to is fed by MNC importers, Original
Increasing incidence of non- have centres of excellence for this in Equipment Manufacturers (OEM),
communicable diseases like heart our country. Structural device therapy Indian MSMEs and a few midsized
failure is a matter of great concern for is a growing area, according to Ghose. corporations who have faced brutal
India owing to the costs associated and unfair competition from their
with it. This adversely impacts Sensing the growing demand for foreign counterparts but still managed
financial spending and puts undue affordable cardiology equipment, to bravely stay afloat.
strain on the economies of countries the government recently put a cap
like ours. Lower economic groups on their prices. Stents are wire-like India-made devices lose out to
which have to spend significant meshes that are used to remove imported devices due to flawed
amount of their income on heart care blocks, largely in the heart. certification and tendering norms, a
will be worst affected. skewed market place and an image
Innovation and smart technologies perception challenge.
This points towards the potential are essential to providing solutions
for cardiology and ECG equipment that address the rising risks of At the current rate of 7-8 per cent rate
to grow in the country. “The cardiovascular diseases. of GDP growth and the government’s
devices industry in expected to see promise to allocate more funds by
a technological revolution in the “Sustainable development begins with increasing GDP spending from
coming decade in India. Equipment promoting a safe and healthy country. 1 to 2.5 per cent in health care
utilised for cardiovascular diagnostics We are entering a significant phase sector; increasing number of both
include ECG, echocardiography where efforts to prioritise investments government and corporate hospitals,
machine, Holter monitor, loop in innovation and research are being cardiovascular equipment market is
recorders, ambulatory BP initiated that can deliver better health poised to see a revolutionary change
instrument, TMT machines, and value for money to our patients,” in coming years.
etc. An ECG is the backbone of says Swaminathan Jayaraman,
cardiovascular diagnostics and used Chairman and Managing Director,
in cardiovascular therapeutics at Vascular Concepts Ltd.
a mass level in our country,” said
Tapan Ghose, Director and Head, Vascular Concepts is a Rs 150-crore
Department of Cardiology, Fortis Flt. Indian company which serves as
Lt. Rajan Dhall Hospital. a global leader in cardiovascular
technology. Founded in 1998, it has
“In keeping with the growth of its corporate headquarters and R&D
cardiac diseases, the number of facility in Bengaluru.
cardiac catheterisation labs is
expected to double in coming years,” Vascular Concepts designs,
he adds. develops, manufactures and markets
endovascular devices that aid less
ehealth.eletsonline.com | JUNE 2017

14
New Technology
POLICYMAKER’S perspective
Rural Landscape As the country is embracing digitisation with a tremendous speed

in various sectors, Chhattisgarh state’s health department is also
not far behind as it is using various digital initiatives to reach
the last mile connectivity in health services, says R Prasanna,
Commissioner, Health Services, Government of Chhattisgarh, in
conversation with Arpit Gupta of Elets News Network (ENN).
R Prasanna
Commissioner, Health Services,
Government of Chhattisgarh
Q What are the various initiatives

undertaken by Directorate
control practices in public health
care facilities. One online portal has
Rashtriya Bal Swasthya Karyakram
(RBSK) The main aim of this scheme
of Health Services using been created for assessment and peer is to detect and manage the 4Ds
Information and Communication review of performance related to prevalent in children of Anganwadi
Technologies (ICT) for improving hygiene, cleanliness and sanitation. Centre (6 weeks to 6 years) and
efficiency of the public healthcare government aided schools (Six years
system? After the assessment, the awards are to 18 years) based screening. These
distributed based on the performance 4Ds are defects at birth, diseases
We have started various e-health and of the facility on the following in children, deficiency conditions
m-health initiatives in the State. Some parameters: and developmental delays including
of them are: disabilities.
• Hospital upkeeping
Human Resource Management Nursing Home Act : This is an online
Information System (HRMIS): • Sanitation and hygiene web portal for any private hospital/
HRMIS is a tool to manage the maternity home/ nursing home, clinic
Human Resource (HR) related tasks • Waste Management and physiotherapy unit, medical
which are being performed in the laboratory or diagnostic services. Any
health department. This project • Infection Control new or established medical facility
captures collective information of can register for license under nursing
health department’s employees. • Support Services home act.
Kayakalp: Kayakalp helps to promote • Hygiene Promotion E- Hospital System : (Implemented

cleanliness, hygiene and infection in three districts hospitals) E-hospital

15
Changing
POLICYMAKER’S perspective
The overall
objective of the
system made easy access to data to Cash incentives under various public financial
generate varied records including health schemes are directly
management
classification based on demographic, transferred to the beneficiaries’
gender, age, and so on hence, bank account. Main schemes are system is to help
enhancing continuity of care. It helps Janani Suraksha Yojna, Family the Directorate of
as a support system for the hospital Welfare Programme and Mitainin Institutional Finance
authorities to develop comprehensive incentives. Salary of contractual
healthcare policies. staff working under National Health
of the Government
Mission is transferred through DBT of Chhattisgarh
E-mahtari : This is online tracking directly to the employees’ salary to identify gaps
system to track due and overdue account. In 2016-17, the department
and weaknesses in
services to be provided to the has transferred Rs. 16 crores to
pregnant women during pregnancy, beneficiaries’ bank accounts expenditure tracking
during delivery and after delivery through DBT. for health sector
and also to the newborn child up
to five years. The aim of e-mahatari Public Financial Management
is to ensure that every woman gets System (PFMS): Public Financial
complete and quality pre- and Management System (PFMS) was
postnatal care and every child receive initially started as a scheme named
a full range of immunisation services. CPSMS of the Planning Commission
in 2008-09. To overcome the
Q Demonetisation has opened

a new scope for cashless
weaknesses of conventional
government financial management
transactions across India, how
Directorate of Health Services is
system and to introduce improved
systems, the last decade has Q mHealth is a very important
component of eHealth. Tell
working to make cashless payment witnessed large scale reforms in the us about medical and public
system across the nation? public financial management systems health practices supported by mobile
in India. devices like mobile phones, patient
We are using the following systems monitoring devices, personal digital
for cashless transactions:
Q What all ICT initiatives the
Ministry is working on or
assistants (PDAs), and other
wireless devices?
Direct Benefit Transfer (DBT): planning to introduce in the
With the aim of reforming near future? Some of the mHealth apps we are
government delivery system by using are:
re-engineering the existing process We are soon going to launch the
in welfare schemes, for simpler and following android applications: CGMSC-Drug Info
faster flow of information/ funds (M-Application):
and to ensure accurate targeting of Health Emergency- Mobile App): This android app provides drug
the beneficiaries, de-duplication and This app provides information about information to its stakeholders,
reduction of fraud Direct Benefit various programmes and schemes doctors, pharmacists and general
Transfer (DBT) was started on 1st of Department of Health and public. Some of the key parameters
January, 2013 by the Government Family Welfare, information about of the drugs like expiry can easily
of India. In Chhattisgarh, DBT Chhattisgarh’s pregnant women be known. It also gives information
was piloted in two districts namely and child vaccination scheduler, about count of the issued medicine
Koriya and Dhamtari in 2013. After Body Mass Index and diabetes risk to any particular facility/district of
successful piloting, it was rolled out calculator and other information for Chhattisgarh, drug which is mostly
across the State in 2014-15. general public. consumed in particular district.

16
industry perspective
India Virtual Hospital:

Empowering Medical
Travellers A professional organisation with doctors, healthcare
professionals, patient guides on board, India Virtual Hospital team
is trained to support and help patients to manage their
medical and surgical care away from home, says Swadeep
Srivastava, Managing Partner, India Virtual Hospital, in
conversation with Elets News Network (ENN).
and Costa Rica. But among these The objective of IVH is to create

corridors of health, India has the an organised, professional and
second largest number of accredited tech-oriented process of ‘decision-
facilities (after Thailand). Bangladesh making’ by empowering patients
and Afghanistan dominate the with right and relevant information
Indian medical tourism market and facilitating them at every step
with approximately 34 per cent for smooth and seamless patient care
share. Similarly, the domestic medical experience. IVH is a tech-enabled
travelers market – patients travelling specialised Medical Concierge Service
Swadeep from smaller cities to metro cities

like Delhi for tertiary care treatment
addressing the needs of Medical
Travelers (domestic & international)
Srivastava
– is growing at a healthy pace. Our looking for quality medical
research shows that about 25% of treatments in Indian Hospitals and
beds are occupied in most hospitals of Health Care Centres. A professional
Managing Partner, Delhi by domestic medical travellers. organisation with doctors, healthcare
India Virtual Hospital This segment offers huge potential. professionals, patient guides on
board, IVH team is trained to support
As the sector gets more organised and help patients to manage their
with serious players like India medical and surgical care away from
Q How do you see the growth of

medical tourism in India?
Virtual Hospital leveraging
technology and filling the numerous
home. The robust technology support
plays an integral role with features
gaps and challenges to improve like electronic medical records, IVH
As healthcare turns costlier in patient treatment journey, the sky is App etc to make the module more
developed countries, India’s medical the limit for India’s medical tourism efficient and scalable.
tourism market is expected to more market. We are fortunate that the
than double in size from $3 billion at government is too supporting this We have for the first time introduced
present to around $8 billion by 2020. sector with much needed reforms. a concept of ‘Patient Happiness
The industry grew at a CAGR of 15 Along with it the push to popularise Index’, which is calculated by
per cent during 2010-15. It says that AYUSH (Ayurveda, Yoga and adding up feedback of the patient
cost is a major driver for nearly 80 Naturopathy, Unani, Siddha and at all the 5 levels of our support
per cent of medical tourists across Homoeopathy) are another major and intervention, which becomes
the globe. The cost-consciousness attractions for international a parameter to judge the success of
factor and availability of accredited medical travellers. our ‘care module’ along with partner
facilities have led to emergence hospitals and doctors and their treatment
of several global medical tourism
corridors - Singapore, Thailand, Q How is India Virtual Hospital
(IVH) pegged to tap the medical
experience given to the patients.
Sandeep Srivastava can be contacted
India, Malaysia, Taiwan, Mexico tourism market of India? at: mp@indiavirtualhospital.com

17
Hospital Companion
A Service for Patient
Convenience A professional service like Hospital Companion, which
handholds the patient and his family members throughout
the treatment journey in an alien city and country is the
need of the hour, says Dr Tarun Sahni, Advisor, India Virtual
Hospital and Senior Consultant, Internal and Hyperbaric
Medicine, Indraprastha Apollo Hospitals-New Delhi, in an
interview with Elets News Network (ENN).
Right from the time when a patient efficient communicator between the
is advised for operation or procedure hospital and the patients. They should
in a metro city, there are numerous act like a patient guide and help the
questions that he faces, who is the patient in selecting the right doctor,
right doctor, hospital, treatment, hospital, treatment and cost. I am
cost, early appointment coupled pleased to share that India Virtual
with queries of stay, commuting and Hospital has come up with such a
insurance. Add to this, the whole model named Hospital Companion.
process of admission to the hospital,
DR Tarun attending the patient, discharge and

recovery process takes a huge toll
The Hospital Companion will provide
end-to-end services to patients and
Sahni
on the patient’s family members their family members in three stages:
financially and mentally. diagnosis stage, hospitalisation stage
Advisor, India Virtual Hospital and and recovery stage. While the patients
Senior Consultant, Internal and You may have come across untoward can contact the hospital and doctors
Hyperbaric Medicine, Indraprastha incidents between hospitals and for their medical needs, they can
Apollo Hospitals-New Delhi family members. Most of these are contact the IVH Hospital Companion
due to lack of communication and for all other need and support.
Q With tertiary care treatment

limited to metro cities such as
misunderstanding, which spoils the
whole patient journey despite medical
Q What are the other benefits of
Delhi, what are the challenges services being of the top quality. “Hospital Companion” especially
faced by domestic and international from hospital’s perspective?
patients?
Q What are the ways to mitigate
the challenges faced by A trained Hospital Companion can
One aspect lacking in Indian patients? smoothen external hurdles for the
healthcare system is the challenges patients with personalised attention
faced due to multiple issues faced by According to me, a specialised service thereby complementing the services
patients and their family members to address these hurdles is the need of of doctors and hospitals. This is useful
during the treatment journey. the hour. in effective communication; during
admission and discharge processes
Unfortunately, almost no one has An experienced professional agency and other support services like
acted upon to comprehensively / service is required who handholds insurance claim, and coordinating
mitigate these challenges as they the patient and his family members with multiple stakeholders on behalf
are not directly related to medical throughout the treatment journey of the patients.
services, but is a huge challenge for in an alien city or country. They Dr Tarun Sahni can be contacted at:
patients and their attendants. should be well versed with hospital advisor@indiavirtualhospital.com,
procedures and can become an www.indiavirtualhospital.com

18
Medical Tourism
SPECIAL FEATURE
Making India Global

Wellness Hub
India’s low cost, skilled medical personnel
and world-class hospital network serve as a
driving force for medical tourism. The other
advantage for India in this space includes the
high degree of medical specialisation in the
country, observes Elets News Network (ENN).
M
edical tourism, which is and world-class hospital network For private healthcare providers
pegged at roughly 25 per serve as a driving force for medical there are opportunities for building
cent year-on-year growth, tourism. The other advantage for hospitals, labs, for training medical
has immense scope in India owing India in this space includes the high workers in partnership with the
to availability of world-class doctors, degree of medical specialisation in country they want to operate in.
excellent medical facilities and a the country.
bouquet of medical services that The domestic medical travellers
covers the whole gamut of modern Another trend that’s fast evolving market – patients travelling from
medicine as well as traditional forms in India, which can be called as a smaller cities to metro cities like
of medicine and yoga. ‘byproduct’ of medical tourism is Delhi for tertiary care treatment –
that many hospitals are starting their is growing at a healthy pace. “Our
“As healthcare turns costlier in operations in African countries. research shows that about 25% of
developed countries, India’s medical While low-cost offered by the Indian beds are occupied in most hospitals
tourism market is expected to more healthcare sector could be one major of Delhi by domestic medical
than double in size from $3 billion at factor making medical travellers from travellers,” Srivastava said.
present to around $8 billion by 2020. developed countries choose India
The industry grew at a CAGR of 15 as their destination to avail quality However, there are still many
per cent during 2010-15. Cost is a services, non-availability of quality issues that need to be resolved
major driver for nearly 80 per cent healthcare in many African, South to help accelerate the growth of
of medical tourists across the globe,” Asian and Middle Eastern countries medical tourism. Lack of ethics and
said Swadeep Srivastava, Managing is opening up a new opportunity for transparency is one major issue that
Partner, India Virtual Hospital. India’s Indian healthcare providers to set up should be resolved by the Indian
low cost, skilled medical personnel their bases in those countries. authorities. Foreigners getting

19
SPECIAL FEATURE
mislead by touts should be looked prowess and a software interface for
into seriuously. health services. Building health cities
in India is also a good opportunity to
Besides, creation of a positive attract foreign medical travellers to
healthcare experience; infrastructure the country.
issues such as transportation and
law and regulatory hurdles be The five pillars of clinical excellence
removed; Integrated infrastructure in the healthcare sector should
for facilitation and ensuring seamless include service excellence, preventive
movement of patients from their healthcare, accessibility to finance and
arrivals to hospitals to their departure quality assurance.By implementing
also need to be addressed by the these five pillars, India has the
industry by taking the government potential to become a global hub for
on board. medical tourism.
If we need to meet both domestic India maintains not only a robust

and international demand in the accreditation system but also a large
healthcare sector, the government number of accredited facilities. With
and the medical fraternity need to government policies geared towards
pool together resources to build ensuring the quality and affordability
excellent hospitals and medical go hand-in-hand, the golden age for
schools across the country. It is also medical tourism in India could just
necessary to build technological be beginning.

Industry Perspective
MAY / 2017
ehealth.eletsonline.com 27
TM
Range of Electromedical Devices

TM TM TM
NEBULIZER NEBULIZER NEBULIZER

HANDYNEB NUPRO SLIMNEB
TM TM TM
NEBULIZER AIR PRESSURE NEBULIZER

NUNEB PRO MATTRESS MININEB
AB01
TM TM TM
AUTOMATIC AUTOMATIC AUTOMATIC

BP MONITOR BP MONITOR BP MONITOR
BP 10 BP 11 BP 12
TM TM
NEEDLE BURNER & OXYGEN

SYRINGE DESTROYER CONCENTRATOR
DOTS OXYTEC-PRO
Innovation
for everyone
Nulife Global Medical Devices Pvt. Ltd.

Corporate Off.: B6, Byculla Service Ind.,
An ISO 9001: 2008
D. K. Marg, Byculla (E), Mumbai-27. INDIA Certified Company
Tel.: 91-22-66578989
E mail : info@nutecmedical.com REGISTERED
FIRM
website: www.nutecmedical.com
22
mCURA: Offering
Effective Solution to
Indian Health System
mCURA, a complete, scalable, and effective solution for the
entire healthcare community, is a very unique way of developing
health records. The solution has an excellent format, which
covers all the basic aspects of a patient, says Dr Paparao
Nadakuduru, Senior Consultant Physician, KIMS Hospital,
Kondapur, in conversation with Elets News Network (ENN).
When we get a database and

analyse it, it helps in prioritising Q Can you share with us some
figures reflecting the positive
areas of prevention, areas of health impact mCURA had on the
promotions. Data helps in gearing patient care?
up the system, thus improving the
Dr Paparao
overall quality of work. mCURA mCURA follows a patient-centric
has a very unique way of developing approach. Availability of information
Nadakuduru
health records. They have an excellent right from the personal data,
format, which covers all the basic physician record, lab investigations,
aspects of a patient. It includes pharmacy and follow-up, helps the
Senior Consultant Physician,
all the details with a provision of physician to check the compliance
KIMS Hospital, Kondapur
attaching all the investigation reports. by the patient. In five-six instances,
The pharmacy requirements are we found that the patients did
also linked to the data base of the not regularly take the prescribed
pharmacy. It’s a very convenient medicine. mCURA allows us to
Q How mCURA has helped the OPD

at the hospital streamline its
single paper. mCURA solution
facilitates handing of all the records to
check whether the patient is taking
the drug after the prescription. Data
processes? the patient through a printout. also facilitates access to information
that how many prescriptions were
Improving the performance of
any healthcare system needs to be Q Can you shed light on how
mCURA is complete, scalable,
honoured by the pharmacy. Initially,
I found that only 29 per cent of my
relooked. Age-old conventional and effective solution for entire prescriptions were honoured and as
systems are going on in the patient healthcare community? we improved the pharmacy facility,
care area. When you aim to improve we could improve it to 85 per cent.
the performance of the healthcare mCURA also provides a complete
system, you need to institutionalise
the networking. It means creating
health record to the patient,
laboratory, radiology and pharmacy. Q How viable is the mCURA
solution in terms of cost?
electronic health records, which It has offered information on how
includes creating the software, many prescriptions are honoured mCURA is an economically
hardware, technical support at the pharmacy. We can access the viable solution for most of the
and ensuring accessibility of the information and the system can alert healthcare organisations in the
technical data. the patient if there are any abnormal country. At a very littile cost, the
results of their investigations. system provides very useful data.

CLOUD BASED CARDIOVASCULAR
INFORMATION SYSTEM CVISS
• Cloud Enabled, Web based Solution for • Distributed PACS for multiple centers
Cardiovascular Information System • Multi modality, Multi patient and Multi view
• Supports AFib, ICD 9 & 10 codes, Cath PCI Enterprise PACS Viewer
Registry and PTCA Registry • Integrated VNA and cloud storage Architecture
• Seamless integration with PACS for accessing • Patient centric and Time line based Work lists
Patient studies like Angio, ECHO, ECG • Archival and publishing on CD, DVD and Blu-ray
• Statistics Module with outputs in multi-color Bar Discs
and Pie Charts • Dockable Toolbar and Filter Panels for Maximized
• Report Generation Utility for single point patient Image View
reporting for any procedure • Seamless integration with HIS, RIS and PACS
• Exhaustive, Powerful and yet dynamic Search Engine • Multi view layout support extended up to 10×10
• Automatically calculates cost of procedure through matrix
trip ticket • Patient Reporting utility for one stop solution
• Editable coronary tree diagram
• Enterprise level CVIS and PACS • Third Party integration for HL7 as well as non-HL7
• Migration of Legacy Patient Image Archives systems
• Vendor Neutral Archive (VNA) • Device interfaces and workflow automation
YOUR SEARCH FOR HIS, CISSCPACS, RISSPACS ENDS HERE...
www.soolinkinternaaonal.com
info@soolinkinternaaonal.com
26
FUJIFILM
Offering Quality
Diagnostic Solutions
for Healthy India
Chander
Shekhar Sibal
Executive Vice President,
Fujifilm India
l i o n
5 bil
1.2 Q Fujifilm is known as a leader
in digital imaging solutions
for healthcare industry. What
differentiates your solutions from
your competitors?
Fujifilm is a leader in digital

With 1.25 billion people to screen and diagnose, the requirement imaging solutions with over 120,000
of proper tele-radiology setup, digitisation tool and the right Computed Radiography (CR) systems
infrastructure is humungous in India. Fujifilm, a leader in digital installed worldwide. In India, too, we
imaging solutions, endeavours to provide best services in the have over 12,000 CR system installed.
remotest areas across the country through digitalisation of We have approximately 50 per cent
X-rays, enabling better image quality at the lowest X-ray dose, market share of the CR market. We
says Chander Shekhar Sibal, Executive Vice President, Fujifilm have over 400 Digital Radiography
India, in an interview with Elets News Network (ENN). (DR) systems installed. Being the

27
first company to bring out the FCR systems in a better way and are able healthcare. We need to focus
101 CR system in 1983, Fujifilm is to treat more patients. Healthcare is on hospitals to make them well
the pioneer in CR systems space. reaching to tier-3 cities and serving equipped with better technologies.
Our systems use ‘Image Intelligence’ villages where various screening The digitisation trend will continue
to assure consistently high quality programmes are initiated by the to be strong in future. Better quality
output. Our systems are user friendly government for healthy India. equipment would improve image
with rugged design and fast service quality and reduce x-ray dose.
response, giving us an edge over the We have observed an emerging
competition. market trend with more doctors Quality Picture Archiving and
going for Flat Panel Digital Communication System (PACS)
Q Access to quality diagnostic

products and solutions is a big
Radiography systems and PACS.
This clearly shows awareness among
and Radiological Information System
(RIS) system would improve the
challenge in tier-2, tier-3 cities doctors about low-dose technologies workflow, efficiency and quality of
and towns across India, what are your and better image quality, coupled reporting, thus providing better and
plans to address this critical issue? with efficiency or faster output to early diagnosis. India is also fighting
patient with clear diagnosis. with increasing non-communicable
We are focusing on increasing diseases like cancer, diabetes and
our market share and customer We are focused on digitising small cardiovascular problems. Early
satisfaction. We are planning to install clinics in small cities and villages diagnosis is most important to treat
systems in smaller places in tier-2 and with our Computed Radiography these diseases. We have developed
tier-3 cities with increased focus on and Digital Radiography and Full Field Digital Mammography
corporate sector, local product and connecting them with tele-radiology (FFDM) with 50 micron resolution
radiology segment. for faster diagnosis. to detect breast cancer at the onset.
Fujifilm India Private Limited has

recently signed a contract with Q What are the key opportunities
you see for Fujifilm in the Indian Q Apprise us about new
innovations and solutions by
Pune-based KRSNAA diagnostics healthcare space? Fujifilm that you think have
Pvt Ltd, a leading diagnostic player in the potential to bring India closer to
the PPP (Private Public Partnership) Imaging technology is very important achieving its universal healthcare
sector, to install 1,000 Computer in India. We have 1.25 billion people goals?
Radiography across India. Our to screen and diagnose, for which
endeavour is to provide best services we require very efficient systems. Living up to our motto, which is
in the remotest areas across the As we have an acute shortage of ‘Value from Innovation’, we are
country through digitalisation of radiologists who can report images committed to provide products
X-rays, enabling better image quality like CT scan, MRI and X-ray, the and services that not only enhance
at the lowest X-ray dose. This would requirement of proper tele-radiology image quality and work flow but
help improve efficiency and quality setup, digitisation tool and the right also keep the patients’ well-being in
of X-ray reporting, resulting in faster infrastructure is humungous. mind by delivering least X-ray dose
and more accurate diagnosis. Our to patients undergoing a procedure.
designs are compact, easy-to-operate I believe that we require robust Fujifilm is into digitisation of X-rays.
and provide high quality outputs with systems as well as electronic medical We sell Computed Radiology and
minimum efforts. records for better quality treatment, Digital Radiology products which
and going forward digitisation would facilitate digitisation of x-ray, coupled
Q How do you see digital imaging

solutions space evolving
help to bring a complete change in
the medical technology. Through
with PACS and RIS to provide faster
access to images to consultants sitting
in India? digitisation, we can now store, in metro cities or big hospitals. This
retrieve images and compare the way efficient and quality diagnostic
In this era of digitisation, the quality graphs of patients to make the process service can be provided to patient
of workflow is getting better and of diagnoses better and effective. in tier-2, tier-3 cities and villages.
the efficiency of professionals is We have point of care dry chemistry
increasing in hospitals. With the Recently, the government has also analysers FDC – NX 500 I, which
help of technological advancement, come up with a new policy with can provide instant results at doctor’s
doctors are able to manage workflow greater emphasis on preventive clinic within a minute.

28
Siemens
Healthineers
Leveraging Technology to
Take on Heart Diseases
Siemens Healthineers India, the pioneer in cardiac CT imaging
in the country, offers leading non-invasive imaging technologies
to diagnose coronary diseases among high risk patients. In an
interview with Elets News Network (ENN), Sanjay David, Head
of CT in India on Cardiovascular CT/Coronary CT Angiography,
Siemens Healthineers India, talks about the accuracy of the
equipment and convenience they offer to the patient.
Sanjay
David
Head of CT in India on
Cardiovascular CT/Coronary
CT Angiography, Siemens
Healthineers India
Q Tell us about Siemens

Healthineers legacy in
is that you can see the coronary
arteries in a non-invasive manner. Q Does it require special skills or
technical knowledge to get the
cardiovascular CT. What are The patient is not required to be coronary CT angiography done
their key advantages? admitted in the hospital for cardiac on the patient?
study. Compared to the traditional
Siemens Healthineers India brought methods for evaluating coronary I think, you need to have the right
cardiac CT to India in the year artery disease, this system gives CT scanner with the required speed
2000. Since then we have launched a you a very high negative predictive and the right temporal resolution
number of products in the Somatom value and a very high sensitivity. because the heart is a beating organ.
series of CT scanner models. We are If the system confirms a coronary The scan has to be fast enough to
the pioneers in cardiac CT imaging. disease, you can be 99 per cent capture good images of the heart as
The advantage of cardiac CT imaging sure of it. it is beating. The heart vessels we

The new
MAGNETOM ESSENZA
is even more powerful now with
syngo MR E11 syngo
MR E11
MAGNETOM ESSENZA is now even more value packed, • DotGO enables expert level image quality consistently
thanks to syngo MR E11. and intuitive protocol management.
• Neurology and MSK examinations with Quiet Suite, • High-resolution, anatomically-accurate DWI imaging
with up to 97% reduction in sound pressure. with RESOLVE.
• Quiet Suite includes QuietX, and inaudible PETRA, a Increase your efficiency. Expand your MRI services.
sequence for 3D T1 imaging.
For business queries,
• Deliver exceptional image quality and speed.
please email us at: hc_contact.india@siemens.com
or you can call our Helpline: 1800-209-1800
siemens.co.in/healthineers
30
see through the imaging equipment the Society of Cardiac CT USA

is the size of a few mm. If you see a and Escorts Hospitals India over
vessel, which is fraction of a cm and the last four years to train the doctors
it is beating at a speed of 5-7 times over this technology.
a second, you also need to have a
good spatial resolution to see the
object of this optic size. Once the Q Are you also looking to expand
the adoption of your coronory
object is imaged a lot of things are CT technology to Tier 2 and
automated through the CT scanner. Tier 3 cities?
A lot of manual interventions that
were required 15 years ago are not We have a range of cardiac CT
required any more. There is a lot of scanners so that it can be affordable
artificial intelligence embedded in for hospitals in Tier 2 cities as well.
our CT scanners, which allows the Some of the big chain hospitals and
doctors to have the results of the same major cardiac hospitals would like to
quality every time scanning is done, have the highest level of technology
irrespective of who is operating and systems, whereas smaller
the machine. hospitals with less number of patients
would go for a lesser sophisticated
Q Does Siemens Healthineers also

provide some kind of training to
technology and systems.
We are the pioneers
the doctors?
Q How are Siemens Healthineers
CT scanners be made available
in cardiac CT imaging.
Once the images are delivered, the to diagnose patients in small The advantage of
final decision whether the patient has villages? cardiac CT imaging is
a coronory disease or not is arrived at
that you can see the
after the doctor evaluates the images. A good example of this is a hospital
This is a very special expertise which in Pune, which has tied-up with coronary arteries
cannot be tought to the application several nearby villages so that the in a non-invasive
specialist team. The specialist team patient can book an appointment and manner.
trains the doctors on how to use the get himself tested. The benefit is that
machine to get the images. We have the patient can go back to his routine
tie-ups with several organisations like work and also get a thoroughly
the Society of Cardiac CT USA and checkup done. This model also
Escorts Hospitals India over the last helps in bringing down the cardiac
four years to train the doctors over diagnosis cost.
this technology.
Q What are the cost implications Q How can early diagnosis of

coronary disease be linked
for the patient as well as with India’s universal
the hospital adopting this healthcare goals?
technology?
Studies have shown that 50 per cent
Once the images are delivered, the of deaths due to heart disease happen
final decision whether the patient has due to the first attack. That means
a coronory disease or not is arrived at the patient does not know that he
after the doctor evaluates the images. has a heart problem. We believe that
This is a very special expertise which this technology will play a big role by
cannot be tought to the application identifying the disease early in high
specialist team. The specialist team risk patients and the patient can be
trains the doctors on how to use the advised to make changes in
machine to get the images. We have the lifestyle.
tie-ups with several organisations like

DS20
DIAGNOSTIC STATION DS20

SIMPLIFY YOUR DAILY WORK
DS20
î Most vital signs and physical assessment tools in one device
î Perfect tool for Atrial Fibrillation Screening: One resting

rhythm channel can be acquired just by connecting only 3
electrodes, without multiple ECG cable connections
î Large interactive touch screen and self-explanatory user
interface for maximum user-friendliness
î 12-lead ECG interpretation, spirometry and Pulse Wave
Analysis (PWA)
î Connectivity to EMR, PACS, HIS for easy data access
DS20 is a Practical and yet Sophisticated Diagnostic Station
For enquiries contact : sales@schillerindia.com | Website : www.schillerindia.com | Toll-Free No. : 1-800-2098998

Swiss H.Q.: Schiller AG, Altgasse 68, P. O. Box 1052, CH - 6341 Baar, Switzerland,
Indian Corporate Ofﬁce: Schiller Healthcare India Pvt Ltd., Advance House, Makwana Rd,
Off. Andheri Kurla Road, Marol Naka Metro Station, Andheri (East), Mumbai - 400 059.
Tel.: + 91- 9323799863, +91-22 61523333/ 29209141 | Fax: +91-22-29209142
E-mail: sales@schillerindia.com, support@schillerindia.com
All registered trademarks acknowledged
Factory : No. 17, Balaji Nagar, Puducherry 605010 CIN : U33110MH1997PTC111307
32
Schiller
PRODUCT LAUNCH
DS20
Making Routine
Check-ups
Modern, Simple &
Faster Designed for spot measurements and
routine check-ups of non-critical patients,
DS20 is its most comprehensive diagnostic
station with unique features like resting
ECG, PWA, and spirometry that enables
physicians to perform tasks in five minutes
with one device, which may otherwise take
20 minutes with multiple devices.
Schiller has recently announced DS20 enables physicians to HL7 protocols. One of
the launch of DS20, its most perform tasks in five minutes its important features,
comprehensive diagnostic station with one device, which may the advanced Pulse Wave
with unique features like resting otherwise take 20 minutes with Analysis (PWA), helps in easier
ECG, PWA, and spirometry. It is multiple devices. It is an ideal tool understanding of hemodynamic
designed for spot measurements for patient induction process in and the process of arterial aging
and routine check-ups of non- a hospital, as the patient’s vital within minutes with graphical
critical patients. In addition to parameters are quickly checked indication, which is useful in
physician offices, retirement on a single platform and the data screening patients for early
homes, hospitals and clinics, DS20 can be automatically transferred evidence of vascular disease and
is a useful tool for routine check- and stored to the Hospital monitoring the response to the
ups in occupational medicine. Information System (HIS) through therapy given.

33
DS20 simplifies daily wORK
• Main vital signs and physical

assessment tools united in one device
• Ideal for arrhythmia and atrial
PRODUCT LAUNCH
fibrillation screening: one resting
rhythm channel for display, storage and
printing with three electrodes • Large,
interactive touch screen • Intuitive
guidance and ease of use
Fast and easy to use

DS20 immediately detects connected
sensors and automatically displays the
corresponding value. This fast operation
allows for easy addition or removal
of parameters. Thanks to its intuitive
user guidance, Schiller’s DS20 is self-
explanatory and very little training is
needed. The large interactive touch
screen supports the highest
user-friendliness.
One touch
Simply touch the large, high-resolution
colour display and you are in business
recording, and selecting the highest
quality ECGs.
• Perform • Review • Store or export
wherever you want
Connected
The DIAGNOSTIC STATION DS20 is a
networked device. Seamless connectivity
to EMR, PACS, HIS or Schiller’s SEMA3
Cardiology Information System is possible
and bidirectional communication allows
for easy data access, while Wi-Fi with
strong security enables direct and fast
transmission.
Expandable
Easily add new functions and other
devices or future technological
developments. The DS20 is ready for the
most common functions and will satisfy
new requirements.
• DS20 on trolley - easy transport
between rooms • DS20 on wall mount
- saves space • One-time patient data
entry - saves time and reduces data
errors • Large display (18.5 inch) - all
information at a glance, no sub-menus
• Touchscreen and intuitive icons - one
touch to measurement • Interface to
scales - automatic weight, height and
BMI measurements

34
Making
Primary Healthcare
Globally, technology is making healthcare affordable and

accessible. In the next few decades the idea of driving
to a doctor’s clinic, waiting and physically meeting the
doctor will be obsolete, says Manasije Mishra, Managing
Director, Indian Health Organisation & Aetna India, in an
interview with Elets News Network (ENN).
Manasije
Mishra
Managing Director,
Indian Health Organisation & Aetna India

35
Service a Reality in india
in our medical partner network, be able to get appropriate treatment,
which includes dentists, diagnostic guidance and motivation to navigate
centres, specialist doctors, medical through the complex healthcare
Q Why preventive healthcare is

important for a country like
centers, hospitals and pharmacies.
With this ecosystem in place, we
system. The service is availed through
voice calling by dialing our toll-free
India? organise blood tests and medicine number and video consultation
delivery at patients’ home, refer through our mobile app vHealth by
The modern sedentary lifestyle, them to appropriate specialists for Aetna.
ignorance of minor health problems consultation in their vicinity at a
and self-medication are among discounted fee. Freedom Membership: Our
the reasons for increasing disease preventive package available at Rs
burden in India. The small amount
of money spent on preventive Q What are your key solutions
and offerings in the preventive
3,650 a year entitles a family of four
members for unlimited vHealth
healthcare indicates that we are healthcare segment? teleconsultations, two free annual
more reactive rather than proactive health check-ups, dental packages
in adopting preventive approach With vHealth by Aetna, which is an and discounts on day-to-day medical
towards health. Lack of access to a integrated primary care ecosystem, expenses including medicines,
good primary healthcare system, we offer a wide range of solutions that diagnostic tests and consultations
increasing healthcare costs and poor cater to varied healthcare needs of from IHO health partner’s network.
doctor to patient ratio are some of an Indian family. There are various
the other reasons for low adoption of packages we offer. Classic Membership: While the
preventive healthcare in India. average health expenses of an urban
vHealth by Aetna: An integrated Indian family range between Rs
To tackle these challenges, Indian primary care ecosystem that provides 20,000 and Rs 35,000, our classic
Health Organisation has recently unlimited teleconsultation for a consultation membership helps
introduced vHealth by Aetna, an family of four members and access to people save up to 50 per cent on their
end-to-end primary healthcare our discount medical partner network health expenses. This membership,
service. At its heart is our own team for a modest price of Rs 2,400 per which costs Rs 5,880 per year,
of doctors, who operate from a state- year. By using vHealth as their entitles a family of four members
of-the-art telemedicine centre. They first point of contact for any health for unlimited teleconsultations with
are supported by 16,500 clinicians concern/query, our members will Swiss telemedicine trained physicians,

36
10 free consultations with any doctor We also ask patients to rate the
in top hospitals, two free annual consultation as well as the overall
health check-ups and discount
To tackle these service.
card for savings on diagnostic tests, challenges, Indian
medicine purchases, dental and other
minor treatment.
Health Organisation
has recently
Q How can healthcare be made
more affordable for masses?
Q How Indian Health Organisation

is contributing in improving
introduced vHealth
by Aetna, an end-
Globally, technology is making
healthcare affordable and accessible.
healthcare delivery in the to-end primary In the next few decades the idea of
country? Who are your important driving to a doctor’s clinic, waiting
partners?
healthcare service. and physically meeting the doctor will
At its heart is our be obsolete. Technology, including
Our team of doctors has completed own team of doctors, smart phones, remote sensors,
over 5,000 consults in three months connected devices, will provide access
who operate from
and we are delighted with the patient to primary care services.
feedback. It makes me proud to say a state-of-the-art
that our doctors at vHealth were able telemedicine centre. During the soft launch of vHealth,
to provide appropriate diagnosis and over 70 per cent of the consults to our
treatment for 70 per cent of the cases telemedicine centre did not require a
which led to avoidance of any further physical follow-up.
medical support. Several patients
commented that we have identified Smart prepaid subscription plans
the root cause of their long-standing can be effectively used to manage
medical problems. Patients were costs while ensuring quality care.
also delighted that they were able to extensive written and practical Our classic consultation membership
get the undivided attention of the assessment. helps our members save about 50
doctor for over 30 minutes with the per cent of their outpatient medical
help of our handholding and follow Our doctors have the ability to expenses.
ups. Apart from managing acute and diagnose patients through scientific
chronic patients, we have helped
diagnose cases like hemochromatosis
evidence-based protocols. If a patient
suffers chronic headaches it could Q What is the current reach of IHO
in the country? Apprise us about
(iron overload), gastric cancer, triple be due to migraine, tension, eye your focus areas and future plans.
vessel disease, nephrology, parkinson- problems, medication, neurological
plus and more. problems, sleep deficiency, cervical We have our pathology and pharmacy
spondylosis, brain tumour, etc. Our network in 300 plus cities and
With our focus to make quality clinical protocols help doctors to specialist medical partner network in
healthcare accessible in India, we probe in a systematic way and unravel 38 cities.
have tied up with Medgate AG, a relevant points. This information
Swiss market leader in telemedicine. along with medical history, India needs a robust primary
They have developed the science of photographs and test reports enable healthcare system, which families
remote diagnosis for over 15 years. us to diagnose or make referrals. can use as their first point of contact
We use detailed medical and training for any health requirement. The
protocols customised for India. We Consistent follow-up with the patient system should be able to help people
also use their patient management throughout the journey of the disease get the right guidance, diagnosis,
system. also helps our doctors assess the and treatment. vHealth by Aetna
response to the treatment and take can fulfill this need. We intend to
We recruit well-qualified and corrective action if required. add one million members to our
experienced doctors from reputed current membership base of half a
institutes. These doctors undergo four Recording of consultations are million. We are confident that with
weeks of telemedicine training and reviewed by our Medical Director, clinical excellence and the widespread
get certified to Swiss telemedicine scored against a detailed checklist and partner network, we will be able to
standards by Medgate after an regular feedback provided. achieve this goal.

NatioNal
SUMMit
38
Healthcare Innovations
Philips
Intelli
Taking Affordable Health Tech Closer to the Masses
april 2017 | ehealth.eletsonline.com

39
Healthcare Innovations
Shankar Seshadri,
Senior Director and Business Head –
Patient Care and Monitoring Solutions
and Ultrasound, Philips India, flagged
off the specially designed mobile van
IntelliSafari from the Gujarat capital
on a 30-day trip, covering key cities in
the state.
Safari
Dr Naman Shastri, Cardiac
Anesthetist, SAL Hospital,
Ahmedabad, said, “A healthcare
provider’s responsibility is to provide
early and accurate diagnosis along
with the best possible treatment. But
the availability of latest technology
Equipped with advanced cutting-edge products and designed to treat at a price that can make it viable for
patientsranging from adults to neonates in ICU, CCU, as well as general hospitals to use them has always been
wards and nursingcare units, Philips IntelliSafari will travel to Tier 2 a big challenge. With Philips taking
and Tier 3 cities of India showcasing the latest in affordable life such an initiative, hospitals can now
saving technologies. focus all their energies on providing
H
patients with the best possible
ealthcare technology major Equipped with advanced cutting-edge healthcare services. Being committed
Philips India on Tuesday products, designed to treat patients to offer healthcare solutions to
showcased its low-cost ranging from adults to neonates in masses, it is our responsibility to
health technology solutions on ICU, CCU, as well as general wards provide early and accurate diagnosis
wheels in Ahmedabad as part of its and nursing care units, the mobile along with the best possible
campaign to reach out to hospitals, van will travel to Rajasthan and other treatment.”
nursing homes and clinics in Tier parts of India after covering Gujarat.
2 and 3 Indian cities with an aim IntelliSafari is a programme that gives
to familiarise them with the latest The equipment on display include healthcare providers in non-metros
affordable innovations in healthcare. Intensive Care Unit, portable patient the opportunity to experience Philip’s
monitoring solutions, networking advanced expertise and technological
“Through the IntelliSafari drive, we solutions, cardiographs (ECG solutions, which brings quality
want to assure people that advanced machines), fetal and maternal healthcare closer to the masses.
technological solutions need not always monitors, defibrillators and AED
come at a cost. Healthcare products devices, and portable ventilator and The expert demonstrators from
which are affordable, and having high- BIPAP devices made by Philips India. Philips help doctors and clinicians
technology features and qualitative to validate the usability of these
solutions are key to increasing access to India has emerged as one of the technologies in a ‘real’ day-to-day
healthcare in India and thereby saving crucial countries for the expansion hospital environment. IntelliSafari
lives,” Seshadri said during the flagging of the Netherlands-based company, was launched by Philips India in
off ceremnony. which last month launched new July 2012 and reached several Tier
diagnostic equipment developed 2 and Tier 3 cities in North India
“As healthcare solution providers, and designed in its R&D centres in the initial phase. The goal of the
we are committed to making that in India and manufactured at programme is to bring new life saving
happen by relentlessly working on its facility at Chakan near Pune technologies closer to the people at an
new technology solutions,” he added. in Maharashtra. affordable price.

40
SPECIAL STORY
YEARS OF
MODI GOVERNMENT
Transforming India’s Healthcare Landscape
T
he last three years have seen using better mobile and internet the world’s attention when it set the
concrete steps that have connectivity; policy interventions to record of most number of people
transformed people’s lives, reduce cost of medicines and medical participating in such an event. The
Prime Minister Narendra Modi equipment; and bringing more people event achieved two things — it
tweeted on the eve of the third under the health insurance net, reinforced India’s image as the world’s
anniversary of his government benefiting millions of patients across leading soft power and furthered the
at the Centre, summing up his the country during the process. government’s aim to promote healthy
government’s achievements. lifestyle in a country that is grappling
When a little over a year in with the serious challenges posed by
For the healthcare sector, the past office, the Modi government lifestyle diseases.
three years saw a slew of measures successfully lobbied to get the
being undertaken to help make United Nations declare June 21 as A slew of schemes including
healthcare more affordable with a the International Yoga Day. The affordable health insurance coverage
sharp focus on empowering citizens mass yoga performance, led by the and the Jan Aushadhi Yojana for
to access quality healthcare services Prime Minister himself, attracted retail sales of generic drugs were

41
The last three years of the
SPECIAL STORY
government, led by
Prime Minister Narendra Modi,
have helped Indian healthcare
system move closer to the set
goals of providing affordable and The National Health Policy looks at
problems and solutions holistically
inclusive healthcare to the citizens. with private sector as strategic
partners. It seeks to promote quality
The government’s interventions of care. The focus is on emerging
diseases and investment in promotive
at the policy front and targeted and preventive healthcare. The policy
is patient centric and quality driven.
programmes have been playing an It addresses health security and ‘Make
in India’ for drugs and devices.In
instrumental role in this endeavour, order to provide access and financial
protection at secondary and tertiary
writes Vivek Ratnakar of care levels, the policy proposes free
drugs, free diagnostics and free
Elets News Network (ENN). emergency care services in all public
hospitals.
introduced in the last two years to in office, said that there has been In order to leverage the pluralistic
make healthcare more affordable. a 6.7 per cent increase in the health care legacy, the policy
coverage under the programme as recommends mainstreaming the
To help digitise healthcare system in compared to 1 per cent in 2014. different health systems. Towards
order to bring more transparency, The government has also opened mainstreaming the potential of
awareness and easy accessibility of 83 outlets under the Affordable AYUSH, the policy envisages better
quality healthcare to the masses, the Medicines and Reliable Implants for access to AYUSH remedies through
government has initiated National Treatment (AMRIT) programme, co-location in public facilities. Yoga
Health Portal and digitisation of serving close to 18 lakhs of patients in would also be introduced much more
government hospital services under three years. According to the health widely in school and work places as
the ‘Digital India Mission’. Keeping up ministry, the AMRIT programme has part of promotion of good health.
with the technological transformation saved Rs 103.55 crores to the patients,
impacting the delivery of services in as “medicines and implants worth Rs As the government has been
the country, various mobile apps like 175. 23 crores were sold for less than opening new AIIMS, the latest being
‘NHP Indradhanush’, ‘NHP Swasthya Rs 71.67 crores”. approved by the Cabinet in Assam,
Bharat’ and ‘Mera Aspatal’ were to address the need for quality health
launched by the Ministry of Health Perhaps the biggest achievements institutions across the country, it
and Family Welfare. for the government in the healthcare would be too early to conclude that
sector came in the form of National India will soon be able to overcome
The immunisation programme, Health Policy and Medical Devices all the challenges. However, it is clear
Mission Indradhanush, has been Rule in 2017. Both these policy that the Modi government at the
successful in reaching to crores of intervention are set to transform the centre is committed to the cause of
children, ensuring they are fully Indian healthcare sector, making the creating a healthy India and the steps
immunised. The ministry in a tweet delivery of services more affordable it has taken so far will go a long way
on the day of completing three years and inclusive. in ensuring that.

42
industry FEATURE
To meet the growing challenge of non-communicable

disease burden in India, cardiovascular diagnostics
medical equipment including ECG, echocardiography
machine, Holter monitor, loop recorders, ambulatory
BP instrument, etc, are expected to see manifold
increase in demand, writes Tapan Ghose, Director and
perspective
Head, Department of Cardiology, Fortis Flt. Lt. Rajan

Dhall Hospital, for Elets News Network (ENN).
Tapan Ghose
Director and Head
Department of Cardiology,
Fortis Flt. Lt. Rajan Dhall Hospital
l a r e
c u ad
a s ec
i o v t D
r d e x h ip
C a N e
tn e
rs
g i n a r
p t t owh e r
n i n i c s p
b
i
u m ma
c
l ee np
s i o u t t e- d to ed s.
va ire rain nce
v i p e r i
p qu r t ie
e y re fo r sc
d
n
E er a c r
s
ea entl eed ula
In urg ng n vas
c
T h is owi dio
gr car
in
43
ted
t h e r projec be on
O uld
x p e n ses wo ses ($0.98
e isea
s p i ra tory d cer ($0.25
re ), can .15
trillion diabetes ($0 alth
), e
trillion and mental h
) .
trillion .03 trillion)
($ 0
A
ccording to the World D’s in healthcare service boom will private-public partnership is urgently
Economic Forum and include doctors and paramedics, drug required to meet the growing need for
Harvard School of Public industry and device industry. trained manpower in cardiovascular
Health, cardiovascular diseases sciences.
top the list of NCDs adding to the Despite having the largest number
projected economic burden between of medical colleges in the world, National Board of Examination is
2012 and 2030. Of the total, NCD producing 30,000 medical graduates required to develop a mechanism
burden of $4.58 trillion, $2.17 trillion and 18,000 specialists annually, to identify the centres of excellence
will be spent on cardiovascular India is far from the World Health in particular area of cardiovascular
diseases alone. Organisation (WHO) norms of one therapeutics and include these
doctor per population of 1,000 (India in the programme, rather than
To meet the growing challenge of has one doctor per 1,319 patients). acting passively as an accreditation
disease burden, India is expected Nurses/ANMs are equally less than body only. Trans-radial coronary
to see doubling of ICU beds and the required norms. intervention and structural heart
equipment utilisation in both private disease therapy should be included
and government sectors by 2030. Short fall of specialists in community in medical curriculum in cardiology.
health centre is 81.2 per cent at Medical collages should focus on
Digital technology, innovative present. Cardiac diseases require applied research as a part of PG
ideas, new business startups, easy highly trained and skilled manpower curriculum relevant to our country.
loan to professionals, lowering for providing the desired services.
of interest rates will open a new There is a huge requirement of Indian pharmaceutical industry’s
chapter in the coming decade in trained cardiovascular man power in contribution is immense not only in
the Indian healthcare sector. Three the country. Increased the India but across the world. India

44
is dubbed as the pharmacy of the devices will be increasingly utilised in

world. Multiple cardiovascular drugs our country.
made in India are available at an
affordable cost. Anti-platelet agents, Heart failure is emerging as a
anti-hypertensive agents, statins, new tsunami in cardiovascular
beta-blockers and anti-diabetic therapeutics. Precise estimate of the
medications are available in most of disease burden in our country is not
the community health centres in known. Based on my experience of
our country. over 25 years in four tertiary care
hospitals (government hospital,
The devices industry in expected trust hospital, corporate hospital), I
to see a technological revolution presume that implantable defibrillator
in the coming decade in India. implantation (ICD), cardiac
Equipment utilised for cardiovascular resynchronisation therapy (CRT-D
diagnostics include ECG, and P) utilisation will grow many fold
echocardiography machine, Holter in coming years in our country.
monitor, loop recorders, ambulatory
BP instrument, TMT machines, This is largely because of residual
etc. An ECG is the backbone of burden of damaged hearts (EF < 35%)
cardiovascular diagnostics. from premature coronary heart disese
in the population. Heart failure will
The full potential of ECG are be a major cause of hospitalisation.
yet to be utilised and used in More number of left ventricular assist
cardiovascular therapeutics at a mass devices (LVAD) will be implanted. In
level in our country. One innovative keeping with growing burden of heart
utilisation of mobile phones is keeping with the growth of cardiac failure population, number of cardiac
ECG and oxygen (SPO2) saturation disease, the number of cardiac transplantation will increase. Cardiac,
monitoring integration. catheterisation labs is expected to renal transplantation, hepatic
double in coming years. transplantation are available in many
While most of the available mobile centres of Fortis Network Hospital &
phones with ECG monitoring give Diagnostics cardiac catheters, other hospitals in our country.
only one lead (Lead I) and can vascular sheaths, wires used in the
be used for rhythm diagnostics, country are mostly imported at Fortis Flt. Lt. Rajan Dhall Hospital
modification of software and present. There is an urgent need for recently completed 1,000th kidney
utilisation of earphone cable could innovation, human trial and patent transplantation successfully. Expert
potentially be used to take all 12 leads application in the area of trans-radial immunologists and immune
recording of an individual. This can and trans-femoral diagnostic catheters suppression agents are available in
be recorded and preserved in the and other disposable devices used in our country. Sufficient donor heart
device and can be transmitted for cardiac sciences.Therapeutic devices and recipients are also available in
interpretation, utilising the digital like coronary stents, peripheral our country. It’s a matter of time that
platform. I have personal experience stents, vascular stent grafts, artificial we see a huge surge in the number of
of a handheld ECG recording heart valves both (mechanical and cardiac transplantations in
instrument from our country. bioprosthetic) valves will be utilised the country.
The device requires refinement. in more numbers. Advent of non-
Because of increasing burden of surgical technique of TAVR (non At the current rate of 7-8 per cent rate
atrial fibrillation in the country, surgical aortic valve replacement) is of GDP growth and the government’s
Holter utilisation will be higher. The a boon for the heart patients. There promise to allocate more funds
Holter monitoring, similarly, can be is an urgent need to have centres of (increasing GDP percentage from 1 to
integrated with the mobile technology excellence for this in our country. 2.5) in health care sector; increasing
and can be used more freely at an Structural device therapy is a growing number of both government and
affordable cost.Rhythm diagnostics area. Devices for cardiac shunts corporate hospitals, cardiovascular
using mobile technology and internet (ASD, PDA devices, vascular colis and healthcare is poised to see a
are already in use in our country. In plugs), left atrial appendage closure revolutionary change in coming years.

SUBSCRIBE TODAY
SUBSCRIPTION ORDER CARD

Duration Issues Subscription Newsstand Subscription Savings
(Year) USD Price INR Price INR
1 12 $300 900 `900 --
2 24 $500 1800 `1500 `300
3 36 $750 2700 `2000 `700
I would like to subscribe
Please fill this form in CAPITAL LETTERS
First Name .................................................................................................. Last Name ...............................................................................................................

Designation/Profession .......................................................................... Organisation ...........................................................................................................
Mailing address ...............................................................................................................................................................................................................................
City .............................................................................................................. Postal code .............................................................................................................
State ............................................................................................................ Country ....................................................................................................................
Telephone ................................................................................................... Fax ............................................................................................................................
Email ........................................................................................................... Website ...................................................................................................................
I/We would like to subscribe for 1 2 3 Years
I am enclosing a cheque/DD No.* ................................................ Drawn on ............................................................................. (Specify Bank)

Dated .................................................................................................... in favour of Elets Technomedia Pvt. Ltd., payable at New Delhi.
For `/US $ ............................................................................................................................................................................................ only
*Please make cheque/dd in favour of Elets Technomedia Pvt. Ltd., payable at New Delhi
Subscription Terms & Conditions: Payments for mailed subscriptions are only accepted via cheque or demand draft • Cash payments may be made in person
• Please add `50 for outstation cheque • Allow four weeks for processing of your subscription • International subscription is inclusive of postal charges.
YOU CAN SUBSCRIBE ONLINE eletsonline.com/subscriptions

Contact: Elets Technomedia Pvt Ltd — Stellar IT Park, Office No: 7A/7B, 5th Floor, Annexe Building, C-25, Sector 62, Noida, Uttar Pradesh 201301,
Phone: +91-120-4812600 Fax: +91-120-4812660, Email: subscription@elets.in
46
CONFERENCE REPORT
Innovations Reshaping Indian

Pharmaceutical Landscape
Delegates at the inaugural ceremony of the elets Pharma CIO Symposium in Mumbai.
India is on the cusp of a momentous paradigm shift new dimension to the growth of the industry globally,
in healthcare. Where on the one hand there is a even as experts stressed that to innovate continously
growing need to improve the existing health delivery “is not a matter of choice anymore and has rather
system, while on the other hand a vibrant ecosystem become a necessity”.
is required to promote innovation and research and Also came up for discussion India’s proven capabilities
development to discover new molecules and reinforce in cutting edge disciplines like chemistry and
India’s reputation as a leader in natural medicines biotechnology, which should be leveraged to make
-- an area that is of late witnessing a number of policy forays into innovations in drugs.
interventions. By an estimate, the industry is all set to expand at
Elets Pharma CIO Symposium held in Mumbai on April a Compound Annual Growth Rate (CAGR) of 16 per
21 offered a grand opportunity for Pharmaceutical cent to $55 billion by 2020. Much of this growth will
CIOs, policy makers, regulators, industry experts and depend on Indian pharma companies’ capacity to adopt
industry stakeholders to come together to deliberate, IT to drive their productivity, improve efficiency and
network and bring in unique synergies to the system maintain cost effectiveness.
and push forward digital adoption to drive innovations. With an eye on the changing scenario in the Indian
The first of its kind Pharma CIO Symposium examined pharma sector, Elets Pharma CIO Symposium has
the growth of Indian pharmaceutical industry from the come as a major breakthrough, helping India develop a
perspective of how Information Technology is adding a vibrant ecosystem to achieve its healthcare goals.
june 2017 | ehealth.eletsonline.com

47
Inaugural Session
CONFERENCE REPORT
A Peek into Innovations in Pharma Industry
VR Shah
Deputy Commissioner
Food and Drug Control Administration, Gujarat
“ Sharing the latest developments in Food and Drug Control Administration

(FDCA) of Gujarat, VR Shah, Deputy Commissioner, FDCA-Gujarat said that
FDCA along with some other state government departments have been
identified under the Right of Citizen to Public Services (RCPS) Act. “The
moment I receive an application, its acknowledgement has to be sent to the
applicant within three days. If there are any documents to be furnished or
there are some lacunas then we have to inform the applicants about them.
An officer is designated to look into the grievances and is assigned a time
limit to dispose off the case. If the officer fails to do so, the applicant has the
right to sue him.”
J Jayaseelan Mayur Parmar Yugal Sikri

Chairman Food and Drug Control Chairman
Indian Drug Manufacturers Administration (FDCA), Pharmaceutical
Association Gujarat Management, School of
“In 1970s, the government took two Business Management &
“Pharma industry is the second most Director, Pharmaceutical
major decisions. The first was removal regulated industry in the world. When
of product patents to enable Indian Technology Management,
it comes to IT adoption, the industry is SPP School of Pharmacy
pharma industry grow. This helped us more reactive than proactive because
to do reverse engineering.The second and Technology
regulations in always top of its mind. Management, NMIMS
major decision was government Consider a situation where one fine
imposing restrictions on imports of University.
morning you find all the data on your
drugs. Although these policies helped “Innovations are happening in india at
computer is lost. That would still be
in the growth of Indian pharma a dramatic pace. In the last 10 years
fine as we can tackle it. But imagine
sector, the negative impact was the a lot of things have disappeared that
that same thing happening with the
migration of companies focused on we thought were part of our lives.
health data of a person. Suppose a
R&D out of India due to removal of We need to look at digitalisation and
patient has been receiving cancer
patent protection. In 2005, when we innovations from the perspective of
treatment through nano-robots and
again became part of the global patent fast changes happening around us.
someone hacks these nano-robots.
system no Indian pharma company I don’t think it’s a choice. It’s rather
So, we need to take care of these
could launch a single molecule on its a necessity. It is mandatory for us
challenges when we adopt IT.”
own. One formulation can fetch, say, to be digitally aware about what’s
$100 million which is good. But one happening around. Business is
new drug can help India earn as much changing dynamics and it’s important
as Rs 50,000 to Rs 70,000 crores for us to keep pace with the change
from just one product.” and understand the new lingo.”
ehealth.eletsonline.com | june 2017

48
CONFERENCE REPORT
Key Takeaways
• In the area of ease of doing business, Gujarat measures the glucose level from the lacrimal
government authorities have identified certain fluid (tears).
areas where officials need to deliver on the • These devices are generating huge data --
commitments. structured as well as unstructutred -- which is
• Earlier, when Gujarat FDCA officials used to go for being used by AI to generate useful information.
an inspection the report could be submitted after • To store and archive the huge amount of data,
about a week or 10 days. But now the report has cloud technology has come up, as also the
to be submitted within 24 hours and the person discipline of analytics.
inspected is able to see that report within the next
• In 2005, when India became part of the global
48 hours.
patent system no Indian pharmaceutical company
• All the agencies concerned will now be collectively could launch a single molecule on its own, although
setting out the dates for routine inspections and the country did well in technological innovations
they will be conducting their respective inspections like special pharma formulations.
on a single day.
• One formulation can fetch, say, around $100
• The Central Drugs Standard Control Organisation million for the country. But one new drug can help
(CDSCO) has opted for e-platform, through which India earn as much as Rs 50,000 to Rs 70,000
each and every retailer and wholesaler will be
crores from just one product.
connected to make available all the data about the
stock of the medicines. • After India became a part of the global patent
system, all the multi-national companies have
• The track and trace system of the inventory is
started coming back to the country for R&D
enabling a drastic shift in the Indian regulatory
because of good availability of talent in basic
functioning. It will be fully focused on
sciences and information technology. Today, no
technological innovation, capacity building of the
R&D can take place without IT.
officers as also of the small and medium sized
manufacturers. • For the next 30-40 years, India needs to focus on
innovations and strengthen its roots in biosimilars
• It’s high time that organisations have a department
and biotechnology.
called digital education where every single
employee of old age or middle age can learn the • India is very good at pharma chemistry. In the
new lingo. first quarter of 2017, of the 171 ANDAs approved
55 were from India. Indian companies are
• Even the largest of pharma organisations do not
continuously having 30-35 per cent of the ANDAs
have digital education department to make every
single employee digitally enabled. filed in the US. Every third ANDA is from India.
• Today, a mobile phone connects us to the people, • The areas for future growth include R&D and
organisations, and a large information highway biosimilar.
(internet) which runs across the globe. • The future growth potential of Ayurveda, Siddha
• Wearable devices are coming out in a big way. and other traditional medicine systems is huge
Innovative products like fibrotronic, which acts for India.
as a sensor to capture health data our body • Despite India being one of the leading the source
generates, have been launched recently. It means country for natural medicines, China enjoys more
that everything is getting connected to the than 90 per cent of the market share.
information highway (internet) -- thanks to the • India needs to find out the active principles in
Internet of Things. each herb. Concerted efforts are required to bring
• Wearable devices are increasingly giving new molecules and products in traditional medicine
information about blood pressure, glucose level and systems.
all other relevant metabolic parameters constantly • Pharma industry attracts the highest foreign direct
round the clock. investment. If it is taken up as a flagship industry it
• In 2016, a contact lense was launched which will help Indian economy to grow further.

49
Key Challenges for Indian Pharma Sector
CONFERENCE REPORT
• Before 2005 Indian pharmaceutical companies APIs then most of the products may not be available
could meet the domestic needs, but after the patent for domestic consumption. Until we are able to make
system came into play only multinational companies APIs at a comparable cost to China, we will not be
could launch any new drug -- although they are able to provide the products at the price NPPA fixes.
partnering with Indian companies for marketing • Unlike formulation business, API business is a 24/7
purposes. business. It is a high power intensity business.
• Indian companies might do well in exports but with Power is a very important component where China
Generic Prescription Code to come into force, the has an edge over India as the cost of power in China
Indian pharma industry needs to find a way to meet is negligible. Any part of India cannot give that kind
the impending challenges. of power support to API industry.
• In the active pharmaceutical ingredient (API) space, • The current government had announced 2015 as
India has proven capabilities. But over dependence the year of API. A lot of talks took place on this
on China for 70-75 per cent of APIs will not augur subject but the API industry is still on its own.
well for India. Unfortunately, Indian manufacturers Nothing happened fruitfully and a lot of decisions
depend on China only for the cheap raw material are still in the pipeline.
and not for any technological reason. • There is requirement for a separate ministry for
• India has a price control mechanism in place. Since pharma industry, as regulatory part is looked after
there is a control on the end product price, Indian by the Health Ministry, export by the Commerce
manufacturers are unable to match the price offered Ministry and pollution control by the Forest Ministry.
by China. The Pharma Department is part of the Chemical and
• There are deliberations happening on imposing Fertilisers Ministry. Since the Pharma Department is
import ban on Chinese products, but unfortunately if newly-formed, no responsibility has been assigned
you are going to put a lot of import burden on China to it, so it does only price control.
Panelists during the inaugural session of elets Pharma CIO Symposium at Vivanta by Taj-President, Mumbai.

50
CONFERENCE REPORT
Industry Presentation
Technology Changing Dynamics of Business
Ajit Sodhi
They were the global leaders making lot of money. But today Tesla is
the most valued company in the US,” he added.
Managing Partner & CTO Tesla changed the whole business model of how a car is produced,
mySingnatureBook sold and how the people are experiencing the whole utilisation of the
car, according to Sodhi.
“ Businesses are changing very fast owing to the accelerating rate “Tesla is making only 70,000 cars a year, while GM is making five
of technological innovations and adoption, said Ajit Sodhi, Managing
million cars a year. Nobody could have thought in their wildest
Partner & CTO, mySingnatureBook, as he cited the example of
dreams that GM will be caught behind. There are a lot more
telecom industry to put his point across to the audience.
companies like these that are changing the whole economies. If you
“I give an example how the telecom industry was started. Way back
in 1800s it took almost 80 plus years before we could see the dial are not changing; and you are not digital your survival is on stake,”
up phone but the technological change from the dial up phone to he said.
Nokia popular model happened in much shorter time. But the smart Our vision ties off with the same thing. We are helping all those
phones came up very fast. Businesses are changing. Today Pfizer’s organisations which are trying to achieve their changed goals in a
competition is not from Eli Lilly but from Qualcomm,” he said. more secure and transparent manner, Sodhi added.
“GM Motors was at one point of time the world’s biggest car maker. He also explained the best practices for digital adoption and how
Ford and GM Motors were running the entire automobile sector. mySignatureBook can help in getting organisations digitised.
Key Takeaways
• Digitisation of pharma sector may reduce haphazard. It has to be very accurate.
development cycle time and cost, evolve patient • All the companies which are 100 per cent digital
care model and comply with industry and are able to grow their revenues much easily
country regulators. as they are able to control their cost, and cost
• Change should happen quickly, but it cannot be impacts their profits -- pushing them further up.

51
Panel Discussion 1
CONFERENCE REPORT
Disruptive Innovations and New Technologies in Pharma
Industry and Engaging Physician/Patient to New Digital Era
Jasmine Gorimar
Head-Technology
Boehringer Ingelheim
“It’s very cliche to say that necessity is the mother of innovation, but
what kind of innovation we are talking about? Is it only in the area of
new drug development? No. Is it innovations in the area of consumerism?
The consumer is changing, their behaviour is changing, their habits are
changing… the whole environment is changing. Not only the internal Indian
pharmaceutical environment is changing, but the global market is changing.
Not only the pharmaceutical market but the behaviours across the industries
are changing. We are talking about not only the changes in the area of
consumerism but also in the area of supply chain management.”
Atul Aslekar Gyan Pandey Amit Singh

Director Chief Information Officer Pharma Sales Director
Nova Lead Pharma Inc Aurobindo Pharma Limited South and South East Asia,
Elsevier
“Talking about disruptive technologies, “Speaking about disruptive
he said that drug discovery and technologies happening in the “Sharing Elsevier’s experience of
development is seeing a huge amount pharma manufacturing, he said that going digital, Amit Singh said that
of data getting generated. “There are disruptions are happening everywhere “Content is the king and we own a lot
a number of opportunities to use big along with digitisation. “The two of content, but the challenge for us
data and connect it way back to the words that resonate on any forum are: was to find out how we are going to
design and development aspects of disruptions and digitisation, which are position ourselves going forward in the
medicines. Particularly in the Indian intricately linked together. It is not future. So, the first part was how to go
context, as the digitisation ramps that digitisation is a new concept but from print to E (electronic). That part is
up, we are quite sure that we will the whole automation or digitisation’s already done now. The next part would
have multiple data points which will impact is now connected across the be how to use the data in terms of big
give lots of insights to the pharma processes end to end. This makes the data analytics or machine learning. A
companies to provide India-specific world more connected. IT is involved lot of these things are being taken up
solutions.” in every aspect from ideation to drug in the pharma industry as well. The
discovery, manufacturing, and from whole idea is how we use the data
supply chain to supplying drugs to the once we have it in the digital format or
end customer. It is again involved in machine learning format. We use the
analysing all those data points to make data to draw certain inferences. We
it more efficient.” believe in helping our customers in the
pharma segment as well as doctors.”

52
CONFERENCE REPORT
Anil Gidwani Ajit Sodhi

Director Managing Partner & CTO
Dana Group mySingnatureBook
“Disruptive innovation is something which is connecting. The people at the bottom of “In the next 5-10 years, we are
the pyramid are using IT. This is disruptive. We are also getting transparent by using going to see personalised care start
IT. The other important disruption is taking place in the monitoring space. We are happening in India. With computing
monitoring trials, representatives and processes. Then you have feedback mechanism, power going up so fast and so cheap,
which is getting fast.” it has become very fast and cheap
On how to use IT disruption in the pharma industry, he said that in the marketing to compute your human genome.
and sales division a sales representative can use an app and can give you an exact We are already witnessing a lot of
picture of his doctor visits. This eliminates the job of the area manager. If he has a research and products coming up in
question, he can send it across to the product manager and get the reply immediately. personalised healthcare. With the
“Similarly, on the manufacturing side we can do even more. For example, we can computing power processing ability
measure the weight of the tablet, the variation between one tablet to another.” is so easily available in cloud that you
“Disruption in IT is introducing transparency. It brings us more closer to each other. can reach out to many patients and
Today, if FDA has a website where pharma companies can upload details of each subjects. Research is also getting very
and every batch produced with detailed specification of each and everything, FDA fast and innovative.”
inspection becomes an online process.”
Panelists deliberating during the panel discussion on ‘Disruptive Innovations and New Technologies in Pharma Industry’.

53
CONFERENCE REPORT
Key Takeaways
• Google Health is putting in a good amount of • Focusing on data integrity and maintaining the
investment to track individuals when they are not record in the paper format will be very costly
sick. The company is going to track people when and also it may not be conclusive to prove to the
they are very young and see how they are fairing auditors that there are no manipulations.
in their health. Based upon that, they are going to • The areas in pharma sector suitable for digitisation
collect a huge amount of data and the analytics will are the factory and the supply chain. If you talk
come into play. about inventory management, the inventory
• Very soon the accountability will be very high for carrying cost in the pharma is too high. If you have
physicians to see whether the services provided by the right supply chain system where you have the
them were really required or not. The tracking and visibility, better planning, better utilisation and self
traceability is going to happen very soon. life, you can deliver in time and avoid millions of
• Big IT companies like Google, IBM and Microsoft, etc dollars of losses. It will eventually be beneficial for
are already making a huge amount of investments the society because drug companies will be able to
into healthcare applications to allow trace and provide drugs at lower costs.
traceability of the transactions that are occurring • Today, in India we have about one million deaths
through Blockchain. because of medical negligence. The number in the
• Auto industry has been very fast in adopting US is also similar. So, if we can actually use the data,
changes on the digital platform. But in the pharma put a context to the data and help physicians a lot of
industry, this adoption has been a bit slow. The quality in terms of measurable outcomes will come
reasons could be seen from the business point of to medicine and that can help drive the next wave of
view or regulations. growth for pharma.
• As pharma is the second most regulated industry • Currently, we are seeing the growth in pharma
in the world, it has to maintain proof of records slowing down. The thing that can help Indian
over a period of time. In India, financial records are pharma get out of the current slowdown is the
maintained till 8 years, but all the batch records of a digital innovation.
particular drug till the time it is in the market. Most • There is the need to use data to help physicians
of the times, these records are on the paper. come out with more measurable outcomes.

54
CONFERENCE REPORT
Panel Discussion 2
Policies for the Pharma Industry -- Challenges and
Opportunities
VR Shah
Deputy Commissioner
Food and Drug Control
Administration, Gujarat
“The scenario between 1970s and 1980s was

an example of opportunity when India decided
to follow the policy of “Patent to Process” and by
reverse engineering the industry grew in leaps
and bounds. But the period from 1994, after India
became a signatory of TRIPS (Trade-Related Aspects
of Intellectual Property Rights) with 10 years
window, can be called as challenge because now
pharma firms cannot replicate the products which
are already in the market. This forced the pharma
industry to either go for exports or domestic list of
off-patent generic drugs. It also forced the pharma
companies to start concentrating on R&D.”
Panelists with their trophies at the elets Pharma CIO Symposium in Mumbai.

55
CONFERENCE REPORT
Dr Pravin Ghadge J Jayaseelan Saisudha Patro
Head-Clinical Chairman Managing Director
Development Indian Drug Manufacturer’s Mundial Pharmaceuticals
Reliance Lifesciences Association Private Limited
“New regulations and government “We are already the top exporting “When we talk about the policies,
policies should not be looked as country in the pharma sector. The we need to see whether these are
roadblocks for the pharma industry. direct challenges for Indian pharma beneficial to entrepreneur, investor
When we are developing molecules companies in this area include fast or the new comer to the marketplace.
for the domestic market, we tend evolving international regulations, As an Indian player, I may have
to be a little relaxed in presenting data integrity and other new concepts. the technology, knowledge and
the data. But the new government The challenge of doing business in good labour, but still I am not so
policy requires manufacturers to a regulated market is very high for competitive because we keep on
present the data in a specific manner. Indian pharma companies. Suppose an paying different types of taxes. Most
So, whatever data we are gathering Indian pharma company has invested of the efforts of the Indian pharma
from clinical trials in India, that data Rs 500 crores in its facility for export. companies are diverted towards cost
is getting recognised elsewhere as Now, an EU auditor coming for saving and increasing sales, rather
well. It underlines the success of the inspection and seeing some differences than focusing on innovations and
regulatory authority.” in the company’s data will immediately R&D.”
issue an import alert on the company.
To get an USFDA approval, a company
needs to invest heavily and wait for
three-four years before starting doing
business. But because of one import
alert, the entire export business of the
company can come to a standstill.”
Madhusudhan N Saraf
Principal and Professor of Pharmacology
Bombay College of Pharmacy
“Pharmaceutical industry is a knowledge-based industry

and the most important component of it is human
resource. Today, we are facing the challenge of availability
of quality human resource. Inspite of the fact that we
have a number of educational education imparting pharma
education, there is a big dearth of quality people who can
cater to the industry. Industry-academic linkage is the
need of the hour.”

56
CONFERENCE REPORT
Key Takeaways
• The key initiatives of the Gujarat FDCA in product quality cannot be checked. This is a new
e-governance space include two portals: DMLA learning for the industry.
and XLN. • In the last three years, top 25 Indian companies
• The XLN portal is especially designed for the chemist have invested more than Rs 22,500 crores in the
shops. Some 33,000 chemists in Gujarat are on this US. They have started their formulation facilities in
portal along with the drug inspectors and all the US. The reason for the step is that even if they
FDCA officials. get an adverse observation there, no import ban is
• Any person can check the credentials of the nearest imposed on them. The problem can be addressed
chemist shop and pharmacist on this portal. Nearly much faster in the US than in India. But no company
14 states have replicated the XLN module. has an API facility there because it is a ‘Red
Category’ industry associated with pollution.
• The XLN website is connected with the FDCA
laboratory in Baroda, Pharmacy Council of Gujarat • Egovernance and Digital documentation is going
and Pharmacy Council of India. The moment a to help Indian pharma companies to meet the
sample is considered not of the standard quality, all challenges of regulated markets.
33,000 stake holders get an SMS alert so that they • There are more than 10,000 pharma companies in
can prevent using that particular batch of India, out of which top 25 companies contribute
the product. 82 per cent of sales. Any policy the government
• Similarly, there is the DMLA website for pharma introduces should think of small and medium
manufacturing firms. It facilitates firms to apply for pharma companies as well.
a product and get permissions online. The database • The latest challenge for small and medium
of 250,000 product permissions granted to the companies comes from the generic medicine code
firms is also available there. or the Uniform Code for Pharmaceutical Marketing
• Very few companies in India are going for eBMR Practices (UCPMP). Once the UCPMP comes in, all
(Evidence-Based Medicine Reviews). If Indian the small and medium marketing companies will
companies have to build their reputation in pharma slowly vanish.
sector, they need to adopt such global best • The small and medium companies should understand
practices. that they have to find out unique products like
• When the US and EU regulators see a small in naturopathy, or have products in bio-similar
difference in the data, they are not bothered about segment.
the end-product quality. They tell the company that • Today, the consumers are becoming more aware and,
since you have not signed on a particular date as therefore, over the counter medicines offer a good
required, your data is not believable. So, the end opportunity for the pharma industry to grow.
Key speakers discussing their ideas at the panel discussion on ‘Leveraging IoT and New Age Technology for the Growth of Pharma Sector’.

57
Panel Discussion 3
CONFERENCE REPORT
Leveraging IoT and New Age Technology for the Growth of
Pharma Sector
Mayur Danait
Chief Information Officer
Lupin
“Lifesciences industry is considered to be laggard

when it comes to adoption of technology. It’s
not so proactive, as some of the other industries
have been. In all fairness, there is a very strong
reason for that. It is the second most tightly
regulated industry. In the last couple of years, we
have also seen a lot of industry headwinds. We
have seen the R&D productivity falling across
the world, competition increasing coupled with
thinning margins and falling prices. We have also
seen the cost of compliance going up, putting a
lot of pressure on manufacturers. I think there
are four areas where IoT will be relevant: one is
drug discovery and development, while others
include manufacturing and supply chain, sales
and marketing, and pharmacovigilance.”

58
CONFERENCE REPORT
Ravi Sharma Devendra Sanjay Moralwar

Chief Information Officer Dhawale Group CIO
Marksans Pharma Limited Director, CIO Advisory & Zydus Cadila
“Speaking on the impact of Internet Digital Consulting
of Things on R&D, Ravi Sharma, Chief KPMG “Wherever you are required to collect
Information Officer, Marksans Pharma data and there is a hinderence in
“In 2012, a student whose name was collecting it, IoT will be utilised there.
Limited, said, “IoT has a big role to play
Jack Andraka won the Smithsonian We don’t have much R&D happening
in organ on the chip in future because
American Ingenuity Award for an early on animal healthcare in India.
lot of studies have been done on the
stage pancreatic cancer test. When he Countries in the Western world are
subject and there will be restrictions
developed that test he did not have already using IoT to collect animal
and people will not volunteer for it. If
any facilities. What the organ on a health data through RFIDs and chips.
some kind of silicon chip is emedded
chip is going to do for a researcher Similarly, wearable patches is not a big
in a human body, it will not have side
is going to promote a ‘do it yourself’ market in India, but it is a big market
effects but we will be able conduct
trend. If you are adept enough in R&D, in the US.”
most of studies on the molecule.”
there is a lot of innovation expected
from this.”
Key Takeaways
• IoT has great potential in manufacturing as it is being made in track and trace. The entire
can play a big role in capturing data at source. industry is looking at it from the compliance
It can help in adoption of proactive approach in point of view. But there are lots of IoT devices
ensuring that a failure does not happen. available in the market today which can also
• Pharma companies are under lot of pressure capture information on the go about all the
to serialise the products. A lot of investment shipments.

BIOMEDICAL
ISO 9001:2008, 13485:2012 Certified | CE
Visit us at:
WASTE MANAGEMENT PRODUCTS Stall No.1B11, Hall No.1

28th, 29th & 30th July 2017
MEETS BIO-MEDICAL WASTE NORMS 2016 Chennai Trade Centre, Chennai
EQUIPMENTS PVT. LTD.
Waste Segregation Trolleys Manual Needle

● Stainless Steel / Mild Steel trolley on castors Cum Syringe Hub Destroyer
● One, Two, three and four compartment waste segregation system.
● Available in 0.8 Ltr. & 3 Ltr. capacity
● Stainless steel trolley on castors.
● Foot operating system for opening of lid.
● Bins can be interchanged as and when required.
● The bins comply UN and NFX standards of safety.
● Autoclave-able and environment friendly, reusable plastic bins as per BMW colour coding.
● Available Bin Sizes 30 Ltrs, 60 Ltrs
Options of Red, Blue, Black,

Yellow, Green & White
Sharp Containers - Eco Series

● Available in 1.2 Ltr. &
5 Ltr. capacity
Wringer Trolley Sharp Containers - H Series

● Available in 0.8 Ltr., 3 Ltr.
● The entire frame of the trolley is made up
& 6 Ltr. capacity
of stainless steel.
● Bucket Capacity is 25 Ltrs. each
● Comes with a utility bin and mop holder.
● Wringer trolley with one, two and four bin
options available.
● High quality down press wringer for
easy squeezing.
● Lockable wheels.
● Long handle for easy handling.
WB-120
● Waste Bins with Foot
Paddle & Wheels
● Available in 120 Ltr.
capacity
Red & Blue Bin Red, Blue, Black,

Yellow, Green
WB (F) 25
ARVS Equipments Private Limited ● Waste bin with foot pedal
● Available in 25 Ltr.
A-98, Sector-1, DSIIDC, Bawana Industrial Area, New Delhi 110 039. INDIA capacity
Write to us at:
Call us at: Red, Blue, Black, Yellow
vishvesh@arvsequipments.com
+91-11-27751793 / 94 / 95 / 96 dilip@arvsequipments.com
+91-9818355977, +91-9873255359 sales@arvsequipments.com
For more information about our products, please visit: www.sharpsandwastecontainers.com
APRIL / 2017
ehealth.eletsonline.com 9
RNI NO. UPENG/2011/38140 | UP/GBD - 140/2017-19 Posting Date: 20 & 25
www.akhilsystems.com
Blood Bank Management

A deeply integrated information system that
tracks the complete blood transfusion cycle from
donation to transfusion.
HIS Equipment Maintenance

A complete maintenance manager that is facilitated
with preventive maintenance- AMC scheduling,
Fixed Asset Register, complaint management
and much more.
Dietary Management
Move your Hospital Miracle Dietary Management ensures the best
nutritional care for the patients with the precaution
towards complete master, diet form, kitchen order entry, extra diet
order and all the other things necessary for the
nutritional care.
digitization with Miracle Linen & Laundry
Automate all the laundry management operations
HIS Ancillary Modules. and ensure the best management of all the linen.
CSSD
Ensure the best patient care by tracking and
monitoring the use of sterilized equipment.
Akhil Systems Pvt. Ltd. 205-206, Vardhman Times Plaza, Plot No. 13, Road No. 44, Pitampura, Commercial
your healthcare IT Partner
Complex, New Delhi-110034. Phone: +9111-42644111, +91 9968464439

eHEALTH - Health

Uploaded by

Copyright:

Available Formats

eHEALTH - Health

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

eHEALTH - Health

Uploaded by

Copyright:

Available Formats

EPORT

volume 12 / issue 06 / JUNE 2017 / ` 75 / US $10 / ISSN 0973-8959

Unfolding Future Growth Potential

special feature special STORY

R PRASANNA SANJAY DAVID SWADEEP SRIVASTAVA CHANDER SHEKHAR SIBAL

EDITOR-IN-CHIEF HYDERABAD BUREAU WEB DEVELOPMENT LEAD

Dr Ravi Gupta Senior Correspondent: Sudheer Goutham Farhan Khan

Senior Correspondent: Poulami Manager, Subscription:

Senior Assistant Editor: Kartik Sharma Anjan Dey

Like us on ehealthmagazine Follow us on ehealthonline Connect with us on ehealthmagazine

Care with confidence

Increased accuracy, higher productivity, maximum uptime and compliance…

Andhra Pradesh Kerala Tamil Nadu Infusion, Syringe Pumps

Gujarat Mumbai Uttar Pradesh Ophthalmology Division

Mob: +91 98403 79116

Why should you Attend ?

Cardiology & ECG

Increasing incidences of non-communicable diseases like heart

JUNE 2017 | ehealth.eletsonline.com

ehealth.eletsonline.com | JUNE 2017

Rural Landscape As the country is embracing digitisation with a tremendous speed

Q What are the various initiatives

Kayakalp: Kayakalp helps to promote • Hygiene Promotion E- Hospital System : (Implemented

JUNE 2017 | ehealth.eletsonline.com

Q Demonetisation has opened

ehealth.eletsonline.com | JUNE 2017

India Virtual Hospital:

and Costa Rica. But among these The objective of IVH is to create

Swadeep from smaller cities to metro cities

Q How do you see the growth of

JUNE 2017 | ehealth.eletsonline.com

DR Tarun attending the patient, discharge and

Q With tertiary care treatment

ehealth.eletsonline.com | JUNE 2017

Making India Global

JUNE 2017 | ehealth.eletsonline.com

If we need to meet both domestic India maintains not only a robust

ehealth.eletsonline.com | JUNE 2017

Range of Electromedical Devices

NEBULIZER NEBULIZER NEBULIZER

NEBULIZER AIR PRESSURE NEBULIZER

AUTOMATIC AUTOMATIC AUTOMATIC

NEEDLE BURNER & OXYGEN

Nulife Global Medical Devices Pvt. Ltd.

When we get a database and

Q How mCURA has helped the OPD

JUNE 2017 | ehealth.eletsonline.com

YOUR SEARCH FOR HIS, CISSCPACS, RISSPACS ENDS HERE...

Fujifilm is a leader in digital

JUNE 2017 | ehealth.eletsonline.com

Q Access to quality diagnostic

Fujifilm India Private Limited has

Q How do you see digital imaging

ehealth.eletsonline.com | JUNE 2017

Q Tell us about Siemens

JUNE 2017 | ehealth.eletsonline.com

see through the imaging equipment the Society of Cardiac CT USA

Q Does Siemens Healthineers also

Q What are the cost implications Q How can early diagnosis of